Get instant access to the public and private companies around the world pursuing stem cell-related research and therapeutic product development. PLUS... This new, expanded 12th Edition also lists companies providing stem cell research products and services, and for-profit cord blood banks.

The 12th Edition of the Guide (June 2010) delivers the global corporate information you need to invest intelligently, stay competitive, find potential strategic partners, and drive successful sales and marketing programs. See the big picture immediately by uncovering patterns, trends and relationships.

The Guide to Stem Cell Research Companies profiles 206 companies, including those whose primary focus is stem cell research, companies that provide stem cell research products and services, and for-profit cord blood banks.

The 12th Edition is completely revised and updated -- nearly 350 changes were made -- to reflect developments since January 2010.

In this 12th edition you will find:

• 127 Private companies
• 60 Public companies
• 52 Non-US companies
• 15 Subsidiaries or business units
• 4 Nonprofits

Included in each listing (when available):

• Senior Management
• Corporate Mission
• Research Focus
• Links to financial or investment pages
• Links to news pages
• All URLS active
• All E-mail Addresses Active

More than 500 active Web links (URLS, e-mail addresses) put you in touch with the latest news and financial data.

353 pages, PDF format (via e-mail); Price: $379.00 
 

Each profile includes complete contact information, senior management, corporate mission, research overview, plus active links to financial/investor Web pages and news release pages, when available.

View a sample listing from the 10th Edition: Click here. (Adobe Reader required.)

PDF format only, via download. US$379.00 

Order a single copy: Click here.

To download the free Adobe software, click on the icon below:

 
NOTE TO COMMERCIAL FIRMS: We reserve the right to deny sale of any of our directory products to anyone who, in our opinion, intends to re-engineer -- in fact, steal -- our databases for use as a commercial mailing list.